Professor Liu Juntian has been engaged in cancer prevention and treatment for nearly 30 years. He is proficient in the prevention and early diagnosis of various malignant tumors, especially in the diagnosis and treatment of benign and malignant breast tumors. Major publications: [1]Dong L, Zhang H, Zhang H, Ye Y, Cheng Y, Li L, Wei L, Han L, Cao Y, Li S, Hao X, Liu J, Yu J. The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families. Cancer Biol Med. 2021 Sep 28;19(6):850–70. doi: 10.20892/j.issn.2095-3941.2021.0011. [2]Zhang R, Wang W, Li F, Zhang H, Liu J. MicroRNA-106b~25 expressions in tumor tissues and plasma of patients with gastric cancers. Med Oncol. 2014 Oct;31(10):243. doi: 10.1007/s12032-014-0243-x. Epub 2014 Sep 14. PMID: 25218271. [3]Wu N, Wei L, Li L, Li F, Yu J, Liu J. Perspectives on the role of breast cancer susceptibility gene in breast cancer. Int J Clin Oncol. 2022 Mar;27(3):495-511. doi: 10.1007/s10147-021-02098-1.
Tianjin Medical University Cancer Institute and Hospital
Tianjin, China
Department of Cancer Prevention Center
Institute, Department or Faculty Head
Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy.
01 Jul 2000 - 01 Dec 2022